ASPH instructs the more malignant breast cancer cells (donors) to synthesize/secrete exosomes delivering designated elements, aiming to reprogram fundamental processes of the less malignant cells (recipients), such as cytoskeleton dynamics, metabolism, stemness and multifaceted metastasis. Here, ASPH is linked to breast cancer.